Oppenheimer cuts target for Xylem stock from USD 158 to USD 150

Published on 10/15/2026 at 13:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 adjusted EPS reached USD 1.46, up 16 percent year over year. Xylem stock costs EUR 91.78 on October 15, 2026 ahead of October 27 results.

Targets, earnings and timing

Oppenheimer set a USD 150.00 target for Xylem on October 14, 2026.
Second-quarter adjusted earnings per share reached USD 1.46, up 16 percent year over year.
Xylem stock trades at EUR 91.78 at 1:18 p.m. CEST at Lang & Schwarz on October 15, 2026.
Third-quarter results are scheduled for October 27, 2026.

Dokumentarische Schwarzweißaufnahme von Arbeitern bei Wartung großer Industriepumpen — Schwarzweiß-Reportage zur Pumpenwartung steht sinnbildlich für Xylem Inc. (US98419M1009) und dessen globale Wasserinfrastruktur-Kompetenz, Illustration mit AI erstellt.

Xylem Inc. (US98419M1009) is trading at EUR 91.78 at Lang & Schwarz on October 15, 2026 at 1:18 p.m. CEST, while Oppenheimer lowered its price target from USD 158.00 to USD 150.00 on October 14, 2026. The analyst house kept its Outperform rating, according to Markets Insider.

Oppenheimer trims its target

The target reduction places execution and second-half growth at the center of the Xylem debate. It also follows other October target changes, including Barclays lowering its target from USD 159.00 to USD 139.00, as reported by Markets Insider.

What does the guidance change mean?

Xylem's second-quarter 2026 adjusted earnings per share reached USD 1.46, a 16 percent increase from the prior year. The quarter also produced revenue of USD 2.34 billion and an adjusted EBITDA margin of 23.3 percent, according to the company's earnings-call transcript carried by Yahoo Finance. Management raised full-year adjusted earnings guidance to USD 5.55-5.70 per share from USD 5.35-5.60, while full-year revenue guidance stood at USD 9.2 billion.

Three dated developments

On July 28, 2026, Xylem reported second-quarter adjusted earnings per share of USD 1.46 against a USD 1.34 consensus estimate. On October 7, 2026, the earnings-call discussion put the full-year adjusted earnings range at USD 5.55-5.70. On October 14, 2026, Oppenheimer cut its target to USD 150.00 from USD 158.00 while retaining Outperform.

The next reporting date

Xylem is scheduled to report third-quarter 2026 results before the US market opens on October 27, 2026, with the conference call set for 9:00 a.m. ET, according to MarketBeat. The same preview lists consensus expectations of USD 1.45 earnings per share and USD 2.28 billion in revenue.

Price stays the market anchor

The current euro quotation gives investors a dated reference point ahead of the results. Xylem is listed on the New York Stock Exchange under ticker XYL, as shown in an SEC filing dated September 29, 2026.

The further course of trading is shown by the continuously updated real-time quote of Xylem stock.